Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abi Williams
Institution:
Adelphi Group (United Kingdom)
Observed institutions:
IQVIA (United Kingdom),
Adelphi Group (United Kingdom),
World Health Organization Regional Office for Europe,
World Health Organization
OpenAlex ID:
A5074908705
How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold
2022
·
Pip Griffiths
, Joel Sims
, et al.
·
Quality of Life Research
·
32
PDF
How do the number of missing daily diary days impact the psychometric properties and meaningful change thresholds arising from a weekly average summary score?
2022
·
Pip Griffiths
, Abi Williams
, et al.
·
Quality of Life Research
·
18
PDF
Psychometric validation of the Ostomy Skin Tool 2.0
2023
·
Gregor Jemec
, Nana Overgaard Herschend
, et al.
·
PeerJ
·
10
Correction: How strong should my anchor be for estimating group and individual level meaningful change? A simulation study assessing anchor correlation strength and the impact of sample size, distribution of change scores and methodology on establishing a true meaningful change threshold
2023
·
Pip Griffiths
, Joel Sims
, et al.
·
Quality of Life Research
·
4
PDF
The relationship between health-related quality of life (HRQoL) and clinical outcomes in patients with advanced renal cell carcinoma (aRCC) in CheckMate (CM) 214.
2022
·
David Cella
, Melissa Hamilton
, et al.
·
Journal of Clinical Oncology
·
2
An evidential framework for evaluating anchor measures in meaningful change research
2026
·
Piper Fromy
, Dara O’Neill
, et al.
·
Advances in Patient-Reported Outcomes
How Do The Number of Missing Daily Diary Days Impact The Psychometric Properties And Study Results Arising From a Weekly Average Summary Score?
2021
·
Pip Griffiths
, Abi Williams
, et al.
·
Research Square
PDF
Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study
2019
·
Annalisa Chiappella
, Thomas E. Witzig
, et al.
·
Blood
Show more works
View as search
Works count:
8
Citation count:
66
H-index:
4
I10-index:
3
Year
Topic
Type